Christopher R. Fenimore's Insider Trades & SAST Disclosures

Showing you 100 results sorted by most recent dates.

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Regeneron Pharmaceuticals,...	R. Fenimore Christopher	SVP Finance & CFO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 730.81 per share.	16 Dec 2024	491	16,265 (0%)	0%	730.8	358,828	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Finance & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Dec 2024	9,979	9,979	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Finance & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Dec 2024	2,591	17,896 (0%)	0%		0	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Finance & CFO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 787.00 per share.	06 Dec 2024	1,140	16,756 (0%)	0%	787	897,180	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Finance & CFO	Sale of securities on an exchange or to another person at price $ 1204.71 per share.	28 Aug 2024	2,237	1,378 (0%)	0%	1204.7	2,694,936	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Finance & CFO	Sale of securities on an exchange or to another person at price $ 1205.49 per share.	28 Aug 2024	928	450 (0%)	0%	1205.5	1,118,695	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Finance & CFO	Sale of securities on an exchange or to another person at price $ 1205.44 per share.	28 Aug 2024	766	200 (0%)	0%	1205.4	923,367	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Finance & CFO	Sale of securities on an exchange or to another person at price $ 1206.15 per share.	28 Aug 2024	450	0 (0%)	0%	1206.2	542,768	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Finance & CFO	Sale of securities on an exchange or to another person at price $ 1205.67 per share.	28 Aug 2024	236	225 (0%)	0%	1205.7	284,538	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Finance & CFO	Sale of securities on an exchange or to another person at price $ 1205.67 per share.	28 Aug 2024	235	225 (0%)	0%	1205.7	283,332	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Finance & CFO	Sale of securities on an exchange or to another person at price $ 1204.79 per share.	28 Aug 2024	228	966 (0%)	0%	1204.8	274,692	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Finance & CFO	Sale of securities on an exchange or to another person at price $ 1206.67 per share.	28 Aug 2024	200	25 (0%)	0%	1206.7	241,334	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Finance & CFO	Sale of securities on an exchange or to another person at price $ 1206.70 per share.	28 Aug 2024	200	25 (0%)	0%	1206.7	241,340	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Finance & CFO	Sale of securities on an exchange or to another person at price $ 1206.30 per share.	28 Aug 2024	200	0 (0%)	0%	1206.3	241,260	Common Stock
Regeneron Pharmaceuticals,...	R. Christopher Fenimore	SVP Finance & CFO	Sale of securities on an exchange or to another person at price $ 953.47 per share.	09 Feb 2024	1,342	16,072 (0%)	0%	953.5	1,279,557	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Finance & CFO	Sale of securities on an exchange or to another person at price $ 954.57 per share.	09 Feb 2024	1,100	14,972 (0%)	0%	954.6	1,050,027	Common Stock
Regeneron Pharmaceuticals,...	Fenimore Christopher R.	SVP Finance & CFO	Sale of securities on an exchange or to another person at price $ 952.62 per share.	09 Feb 2024	1,046	17,414 (0%)	0%	952.6	996,441	Common Stock
Regeneron Pharmaceuticals,...	Fenimore Christopher R.	SVP Finance & CFO	Sale of securities on an exchange or to another person at price $ 955.00 per share.	09 Feb 2024	600	14,372 (0%)	0%	955	573,000	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Finance & CFO	Sale of securities on an exchange or to another person at price $ 951.39 per share.	09 Feb 2024	487	18,460 (0%)	0%	951.4	463,327	Common Stock
Regeneron Pharmaceuticals,...	Fenimore Christopher R.	SVP Finance & CFO	Sale of securities on an exchange or to another person at price $ 950.49 per share.	09 Feb 2024	344	18,947 (0%)	0%	950.5	326,969	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 555.67 per share.	23 Jan 2024	5,000	21,860 (0%)	0%	555.7	2,778,350	Common Stock
Regeneron Pharmaceuticals,...	Fenimore Christopher R.	SVP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	5,000	0	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	R. Christopher Fenimore	SVP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	5,000	0	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Fenimore Christopher R.	SVP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 399.66 per share.	23 Jan 2024	5,000	22,874 (0%)	0%	399.7	1,998,300	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Payment of exercise price or tax liability using portion of securities received from the company at price $ 948.50 per share.	23 Jan 2024	3,986	17,874 (0%)	0%	948.5	3,780,721	Common Stock
Regeneron Pharmaceuticals,...	R. Fenimore Christopher	SVP Controller	Payment of exercise price or tax liability using portion of securities received from the company at price $ 948.50 per share.	23 Jan 2024	3,583	19,291 (0%)	0%	948.5	3,398,476	Common Stock
Regeneron Pharmaceuticals,...	Christopher Fenimore R.	SVP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Jan 2024	5,000	5,000	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Jan 2024	5,000	5,000	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Christopher Fenimore R.	SVP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 399.66 per share.	03 Jan 2024	5,000	20,329 (0%)	0%	399.7	1,998,300	Common Stock
Regeneron Pharmaceuticals,...	R. Christopher Fenimore	SVP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 555.67 per share.	03 Jan 2024	5,000	19,372 (0%)	0%	555.7	2,778,350	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Payment of exercise price or tax liability using portion of securities received from the company at price $ 912.30 per share.	03 Jan 2024	4,043	15,329 (0%)	0%	912.3	3,688,429	Common Stock
Regeneron Pharmaceuticals,...	R. Fenimore Christopher	SVP Controller	Payment of exercise price or tax liability using portion of securities received from the company at price $ 912.30 per share.	03 Jan 2024	3,469	16,860 (0%)	0%	912.3	3,164,769	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Sale of securities on an exchange or to another person at price $ 856.71 per share.	27 Dec 2023	2,448	14,372 (0%)	0%	856.7	2,097,226	Common Stock
Regeneron Pharmaceuticals,...	Fenimore Christopher R.	SVP Controller	Sale of securities on an exchange or to another person at price $ 844.09 per share.	21 Dec 2023	1,224	17,070 (0%)	0%	844.1	1,033,166	Common Stock
Regeneron Pharmaceuticals,...	R. Christopher Fenimore	SVP Controller	Sale of securities on an exchange or to another person at price $ 843.79 per share.	21 Dec 2023	456	18,294 (0%)	0%	843.8	384,768	Common Stock
Regeneron Pharmaceuticals,...	R. Christopher Fenimore	SVP Controller	Sale of securities on an exchange or to another person at price $ 846.27 per share.	21 Dec 2023	250	16,820 (0%)	0%	846.3	211,568	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Payment of exercise price or tax liability using portion of securities received from the company at price $ 856.71 per share.	12 Dec 2023	2,552	18,750 (0%)	0%	856.7	2,186,324	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Dec 2023	8,499	8,499	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Christopher Fenimore R.	SVP Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Dec 2023	2,370	22,838 (0%)	0%		0	Common Stock
Regeneron Pharmaceuticals,...	Fenimore Christopher R.	SVP Controller	Payment of exercise price or tax liability using portion of securities received from the company at price $ 844.09 per share.	08 Dec 2023	1,276	21,562 (0%)	0%	844.1	1,077,059	Common Stock
Regeneron Pharmaceuticals,...	Fenimore R. Christopher	SVP Controller	Payment of exercise price or tax liability using portion of securities received from the company at price $ 843.79 per share.	08 Dec 2023	474	20,468 (0%)	0%	843.8	399,956	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Payment of exercise price or tax liability using portion of securities received from the company at price $ 844.09 per share.	08 Dec 2023	260	21,302 (0%)	0%	844.1	219,463	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Aug 2023	7,000	10,000	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 399.66 per share.	23 Aug 2023	7,000	26,140 (0%)	0%	399.7	2,797,620	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Payment of exercise price or tax liability using portion of securities received from the company at price $ 842.66 per share.	23 Aug 2023	5,198	20,942 (0%)	0%	842.7	4,380,147	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Sale of securities on an exchange or to another person at price $ 806.47 per share.	23 Mar 2023	2,192	18,409 (0%)	0%	806.5	1,767,782	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	03 Feb 2023	5,000	0	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 270.43 per share.	03 Feb 2023	5,000	23,581 (0%)	0%	270.4	1,352,150	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Payment of exercise price or tax liability using portion of securities received from the company at price $ 774.29 per share.	03 Feb 2023	3,286	20,295 (0%)	0%	774.3	2,544,317	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Dec 2022	7,111	7,111	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Dec 2022	1,926	18,581 (0%)	0%		0	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Gift of securities by or to the insider at price $ 0.00 per share.	09 Dec 2022	871	0 (0%)	0%		0	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Gift of securities by or to the insider at price $ 0.00 per share.	09 Dec 2022	436	461 (0%)	0%		0	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Gift of securities by or to the insider at price $ 0.00 per share.	09 Dec 2022	435	460 (0%)	0%		0	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Payment of exercise price or tax liability using portion of securities received from the company at price $ 753.28 per share.	09 Dec 2022	247	16,655 (0%)	0%	753.3	186,060	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Sale of securities on an exchange or to another person at price $ 749.00 per share.	05 Oct 2022	1,844	16,425 (0%)	0%	749	1,381,156	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Sale of securities on an exchange or to another person at price $ 724.00 per share.	03 Oct 2022	3,346	18,269 (0%)	0%	724	2,422,504	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Apr 2022	5,000	5,000	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 270.43 per share.	08 Apr 2022	5,000	30,066 (0%)	0%	270.4	1,352,150	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Payment of exercise price or tax liability using portion of securities received from the company at price $ 736.21 per share.	08 Apr 2022	3,451	26,615 (0%)	0%	736.2	2,540,661	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Apr 2022	2,450	10,000	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 555.67 per share.	08 Apr 2022	2,450	27,221 (0%)	0%	555.7	1,361,392	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Payment of exercise price or tax liability using portion of securities received from the company at price $ 736.21 per share.	08 Apr 2022	2,155	25,066 (0%)	0%	736.2	1,586,533	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 270.43 per share.	31 Mar 2022	10,000	31,628 (0%)	0%	270.4	2,704,300	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2022	10,000	10,000	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Payment of exercise price or tax liability using portion of securities received from the company at price $ 700.99 per share.	31 Mar 2022	6,857	24,771 (0%)	0%	701.0	4,806,688	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 555.67 per share.	31 Mar 2022	2,000	23,425 (0%)	0%	555.7	1,111,340	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2022	2,000	12,450	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Payment of exercise price or tax liability using portion of securities received from the company at price $ 700.99 per share.	31 Mar 2022	1,797	21,628 (0%)	0%	701.0	1,259,679	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Payment of exercise price or tax liability using portion of securities received from the company at price $ 664.34 per share.	11 Dec 2021	270	21,122 (0%)	0%	664.3	179,372	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Dec 2021	7,941	7,941	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Dec 2021	1,859	21,392 (0%)	0%		0	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	SVP Controller	Payment of exercise price or tax liability using portion of securities received from the company at price $ 664.85 per share.	20 Aug 2021	8,719	19,020 (0%)	0%	664.8	5,796,827	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2020	10,000	10,000	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2020	1,750	21,102 (0%)	0%		0	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Dec 2020	969	19,352 (0%)	0%		0	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Gift of securities by or to the insider at price $ 0.00 per share.	09 Dec 2020	50	0 (0%)	0%		0	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Gift of securities by or to the insider at price $ 0.00 per share.	09 Dec 2020	25	25 (0%)	0%		0	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Gift of securities by or to the insider at price $ 0.00 per share.	09 Dec 2020	25	25 (0%)	0%		0	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 179.13 per share.	20 Jul 2020	10,000	25,277 (0%)	0%	179.1	1,791,300	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jul 2020	10,000	13,500	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Payment of exercise price or tax liability using portion of securities received from the company at price $ 655.57 per share.	20 Jul 2020	6,291	18,986 (0%)	0%	655.6	4,124,191	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.03 per share.	20 Jul 2020	2,224	21,210 (0%)	0%	52.0	115,715	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jul 2020	2,224	0	-		-	Incentive Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Sale of securities on an exchange or to another person at price $ 641.58 per share.	20 Jul 2020	855	19,491 (0%)	0%	641.6	548,551	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Sale of securities on an exchange or to another person at price $ 643.49 per share.	20 Jul 2020	691	18,124 (0%)	0%	643.5	444,652	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Sale of securities on an exchange or to another person at price $ 642.39 per share.	20 Jul 2020	676	18,815 (0%)	0%	642.4	434,256	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Sale of securities on an exchange or to another person at price $ 638.51 per share.	20 Jul 2020	306	20,534 (0%)	0%	638.5	195,384	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Sale of securities on an exchange or to another person at price $ 644.57 per share.	20 Jul 2020	303	17,821 (0%)	0%	644.6	195,305	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Sale of securities on an exchange or to another person at price $ 636.56 per share.	20 Jul 2020	216	20,994 (0%)	0%	636.6	137,497	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Sale of securities on an exchange or to another person at price $ 646.82 per share.	20 Jul 2020	155	17,594 (0%)	0%	646.8	100,257	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Sale of securities on an exchange or to another person at price $ 637.88 per share.	20 Jul 2020	154	20,840 (0%)	0%	637.9	98,234	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Sale of securities on an exchange or to another person at price $ 640.61 per share.	20 Jul 2020	113	20,346 (0%)	0%	640.6	72,389	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Sale of securities on an exchange or to another person at price $ 647.79 per share.	20 Jul 2020	82	17,512 (0%)	0%	647.8	53,119	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Sale of securities on an exchange or to another person at price $ 639.64 per share.	20 Jul 2020	75	20,459 (0%)	0%	639.6	47,973	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Sale of securities on an exchange or to another person at price $ 645.33 per share.	20 Jul 2020	72	17,749 (0%)	0%	645.3	46,464	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Sale of securities on an exchange or to another person at price $ 658.00 per share.	20 Jul 2020	11	17,501 (0%)	0%	658	7,238	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.03 per share.	15 Jun 2020	7,226	20,323 (0%)	0%	52.0	375,969	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jun 2020	7,226	0	-		-	Non-Qualified Stock Option (right to buy)
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Payment of exercise price or tax liability using portion of securities received from the company at price $ 587.90 per share.	15 Jun 2020	3,670	16,653 (0%)	0%	587.9	2,157,593	Common Stock
Regeneron Pharmaceuticals,...	Christopher R. Fenimore	VP Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jun 2020	2,180	0	-		-	Incentive Stock Option (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades